Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00839995 · ClinicalTrials.gov registry record

Use of ROTEM for Multi-level Spine Surgery

A clinical trial, sponsored by Weill Medical College of Cornell University.

Completed
Registry status
41
Enrollment target

NCT00839995 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 41 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00839995 has completed, sponsored by Weill Medical College of Cornell University.

COMPLETED
Registry status
41 participants
Enrollment target

Study Summary

The purpose of this study is to obtain coagulation profiles of patients undergoing multi-level spine surgeries with ROTEM® and routine coagulation tests. The investigators will compare the data from ROTEM® and routine coagulation tests with each other and with blood loss and transfusion therapies used.

Trial Details

FieldValue
Enrollment Target 41 participants
Start Date 2009-02
Est. Completion 2011-12

What the Registry Record Tells You About NCT00839995

The ClinicalTrials.gov registry entry for NCT00839995 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 41 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT00839995 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00839995 about?

NCT00839995 is a clinical study titled "Use of ROTEM for Multi-level Spine Surgery". The purpose of this study is to obtain coagulation profiles of patients undergoing multi-level spine surgeries with ROTEM® and routine coagulation tests. The investigators will compare the data from ROTEM® and routine coagulation tests with each other and with blood loss and transfusion therapies us...

What is the current status of trial NCT00839995?

This trial is currently completed. The enrollment target is 41 participants. The study started on 2009-02. Estimated completion is 2011-12.

Who is sponsoring clinical trial NCT00839995?

This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.